Home › Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate
 

Keywords :   


Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

2015-02-03 14:17:18| Agriculture - Topix.net

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

Tags: trial drug phase patient

Category:Agriculture and Forestry

Latest from this category

All news
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Heifers and female cows remain hot topic at sale barn
17.05Noble Research Institute to study regenerative agriculture practices in pecan silvopasture
17.05Feeding America finds highest level of money needed for food security in 20 years
17.05Cooking temperatures sufficient to kill H5N1 in meat
17.05USDA awards $22.2 million to protect livestock health
17.05USDA awards $22.2 million to protect livestock health
Agriculture and Forestry »
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »